Machine Learning-Based Radiomics for Differentiating Pancreatic Lesions: A Potential Tool to Enhance Clinical Decision-Making and Nursing Management

基于机器学习的放射组学在胰腺病变鉴别中的应用:一种增强临床决策和护理管理的潜在工具

阅读:2

Abstract

BACKGROUND: The noninvasive diagnosis of pancreatic lesions is a critical clinical challenge. This study aims to create machine learning (ML) radiomic models for differentiating pancreatic lesions and an integrated model for pancreatic ductal adenocarcinoma (PDAC) detection. METHODS: 640 patients with pathologically confirmed malignant (n = 450), borderline (n = 108), or benign (n = 82) lesions were enrolled and divided into training (70%) and validation (30%) cohorts. Radiomic features were extracted from regions of interest on arterial and venous phase CT scans. LASSO logistic regression was used to select 36 features for building ML models, including random forest, logistic regression, support vector machine, and artificial neural networks. An integrated nomogram combining radiomic features and CA19-9 levels was developed to distinguish PDAC from borderline tumors. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis. RESULTS: All ML models effectively differentiated the three tumor types. The random forest algorithm showed the best performance, achieving an area under the curve (AUC) of 0.99 and 0.95 in the training and validation sets, respectively. CA19-9 was identified as an independent diagnostic factor for PDAC. The nomogram integrating radiomics and CA19-9 achieved an AUC of 0.89 and accuracy of 0.85 in the training set, with corresponding values of 0.85 and 0.82 in the validation set. CONCLUSIONS: Radiomics-based ML models effectively differentiated benign, borderline, and malignant pancreatic tumors. The nomogram combining radiomic features with CA19-9 demonstrated robust performance, showing considerable potential to streamline the diagnostic process and facilitate timely care planning for patients with suspected pancreatic cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。